HCAT (Health Catalyst) 10-Year Sortino Ratio: N/A (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HCAT Health Catalyst Inc HCAT
49 GF Score
Price $1.70
GF Value $4.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Health Catalyst 10-Year Sortino Ratio?

The 10-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past ten years. As of today (2026-09-12), Health Catalyst's 10-Year Sortino Ratio is Not available.


Health Catalyst  (NAS:HCAT) 10-Year Sortino Ratio Explanation

The 10-Year Sortino Ratio inidicates the risk-adjusted return of an investment over the past ten year. It is calculated as the annualized result of the average ten-year monthly excess returns divided by the standard deviation of negative returns in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

Differnt from the Sharpe Ratio that penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only those returns falling below a user-specified target or required rate of return. The expected returns here is set to the risk-free rate as well.


Health Catalyst 10-Year Sortino Ratio Related Terms


HCAT vs DH, CCLD, OPRX: 10-Year Sortino Ratio Comparison

For the Health Information Services subindustry, Health Catalyst's 10-Year Sortino Ratio, along with its competitors' market caps and 10-Year Sortino Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst 10-Year Sortino Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's 10-Year Sortino Ratio distribution charts can be found below:

* The bar in red indicates where Health Catalyst's 10-Year Sortino Ratio falls into.


HCAT
49GF Score
Health Catalyst Inc HCAT
10-Year Sortino Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Catalyst 10-Year Sortino Ratio Calculation

The 10-Year Sortino Ratio measures the risk-adjusted return of an investment asset or portfolio in the last ten year, focusing specifically on downside risk rather than total risk. A stock / portfolio's 10-Year Sortino Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the downside risks over the past ten year.

A downside risk is a potential loss from the asset or investment. The Downside risk here is measured by the downside deviation, which is the standard deviation of negative returns.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $1.70 is trading 57.8% below its estimated GF Value™ of $4.03. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • 10-Year Sortino Ratio: N/A
  • GF Value™: $4.03 vs. price of $1.70 (57.8% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score

Get the complete analysis for HCAT

10-Year Sortino Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.70
Price
$4.03
GF Value